Tags

Type your tag names separated by a space and hit enter

Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study.
Am J Psychiatry 1992; 149(3):391-3AJ

Abstract

The authors compared vitamin E with placebo in a double-blind randomized crossover study of 27 patients with tardive dyskinesia. Each treatment period lasted for 6 weeks. Vitamin E showed no differences from placebo in the treatment of tardive dyskinesia.

Authors+Show Affiliations

Centre de recherche Université Laval Robert-Giffard, Department of Psychiatry, Laval University, Beauport, Quebec, Canada.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

1346951

Citation

Shriqui, C L., et al. "Vitamin E in the Treatment of Tardive Dyskinesia: a Double-blind Placebo-controlled Study." The American Journal of Psychiatry, vol. 149, no. 3, 1992, pp. 391-3.
Shriqui CL, Bradwejn J, Annable L, et al. Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study. Am J Psychiatry. 1992;149(3):391-3.
Shriqui, C. L., Bradwejn, J., Annable, L., & Jones, B. D. (1992). Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study. The American Journal of Psychiatry, 149(3), pp. 391-3.
Shriqui CL, et al. Vitamin E in the Treatment of Tardive Dyskinesia: a Double-blind Placebo-controlled Study. Am J Psychiatry. 1992;149(3):391-3. PubMed PMID: 1346951.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study. AU - Shriqui,C L, AU - Bradwejn,J, AU - Annable,L, AU - Jones,B D, PY - 1992/3/1/pubmed PY - 1992/3/1/medline PY - 1992/3/1/entrez SP - 391 EP - 3 JF - The American journal of psychiatry JO - Am J Psychiatry VL - 149 IS - 3 N2 - The authors compared vitamin E with placebo in a double-blind randomized crossover study of 27 patients with tardive dyskinesia. Each treatment period lasted for 6 weeks. Vitamin E showed no differences from placebo in the treatment of tardive dyskinesia. SN - 0002-953X UR - https://www.unboundmedicine.com/medline/citation/1346951/Vitamin_E_in_the_treatment_of_tardive_dyskinesia:_a_double_blind_placebo_controlled_study_ L2 - https://ajp.psychiatryonline.org/doi/full/10.1176/ajp.149.3.391?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -